Lupin Limited is a transnational pharmaceutical company. The Company produces a range of generic and branded formulations and bulk drugs. The Company along with its subsidiaries has manufacturing locations spread across India and Japan with trading and other incidental and related activities extending to world markets. The Company�s product basket consists of formulations from Cephalosporins, CVS, CNS, Anti-Asthma, Anti-TB, Diabetology, Dermatology, GI, and other therapy segments . The Company�s products include Cephalexin, Cefaclor, Ethambutol, Prasugrel, Rasagiline Mesylate, Lacosamide, and Febuxostat. Its brands include AKT 2, AKT3, AKURIT3, BUDAMATE 100 TRANSCAPS, BUDAMATE 100 HFA TRANSHALER, BUDATE 100 HFA TRANSHALER (MDI), and BUDATE 200 HFA TRANSHALER (MDI). The Company�s Drugs and products reach over 100 countries in the world.